Latest Breaking News On - Jacques bouchyevp investor relations business development - Page 1 : comparemela.com

Kineta to Participate in H C Wainwright Virtual @Home Fireside Chat Series

Kineta to Participate in H C Wainwright Virtual @Home Fireside Chat Series
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Robert burnsShawn iadonatoThierry guillaudeuxBruce macklelifesci advisorsJacques bouchyevp investor relations business developmentKineta incHome fireside chat seriesChief executive officerChief scientific officerFireside chathostManaging directorSenior healthcare analystregistrationStatements regarding forward lookingPrivate securities litigation reform actAnnual reportQuarterly reports

Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors

Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesShawn iadonatoThierry guillaudeuxBruce macklelifesci advisorsMerck co incMerck sharp dohmeJacques bouchyevp investor relations business developmentKineta incInitial combination cohortDemonstrated dose proportional inductionPro inflammatory biomarkers requiredStrong anti tumorInitial combination clinical data anticipatedChief executive officerReceptor occupancyChief scientific officer

Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer

Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thierry guillaudeuxShawn iadonatoJohn mullalylifesci advisorsJacques bouchyevp investor relations business developmentKineta incTherapy against poorly immunogenicHighly potentNew immune checkpoint inhibitorPromising therapy against poorly immunogenicChief scientific officerChief executive officerStatements regarding forward lookingPrivate securities litigation reform actAnnual reportQuarterly reports

Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit

Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesThierry guillaudeuxKineta incJacques bouchyevp investor relations business developmentJohn mullalylifesci advisorsAnnual macrophage directed therapies summitChief scientific officerEngineered iggCombination with pembrolizumabAdvanced solid tumorspresenterBusiness development

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting

Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer s (SITC) 38th Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Shawn iadonatoThierry guillaudeuxJacques bouchyevp investor relations business developmentSociety for immunotherapy of cancerKineta incSan diego convention centerJohn mullalylifesci advisorsFavorable clinical safetyTolerability profile observedCombination therapy clinical data anticipatedChief scientific officerChief executive officerAbstract numberTime locationExhibit hallsDiego convention